{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"institution":[{"name":"bioRxiv"}],"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T20:52:42Z","timestamp":1768510362685,"version":"3.49.0"},"posted":{"date-parts":[[2024,1,29]]},"group-title":"Pharmacology and Toxicology","reference-count":45,"publisher":"openRxiv","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"accepted":{"date-parts":[[2024,1,29]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                <jats:p>\n                  The neglected tropical disease schistosomiasis infects over 200 million people worldwide and is treated with just one broad spectrum antiparasitic drug (praziquantel). Alternative drugs are needed in the event of emerging praziquantel resistance or treatment failure. One promising lead that has shown efficacy in animal models and a human clinical trial is the benzodiazepine meclonazepam, discovered by Roche in the 1970\u2019s. Meclonazepam was not brought to market because of dose-limiting sedative side effects. However, the human target of meclonazepam that causes sedation (GABA\n                  <jats:sub>A<\/jats:sub>\n                  Rs) are not orthologous to the parasite targets that cause worm death. Therefore, we were interested in whether the structure of meclonazepam could be modified to produce antiparasitic benzodiazepines that do not cause host sedation. We synthesized 18 meclonazepam derivatives with modifications at different positions on the benzodiazepine ring system and tested them for\n                  <jats:italic>in vitro<\/jats:italic>\n                  antiparasitic activity. This identified five compounds that progressed to\n                  <jats:italic>in vivo<\/jats:italic>\n                  screening in a murine model, two of which cured parasite infections with comparable potency to meclonazepam. When these two compounds were administered to mice that were run on the rotarod test, both were less sedating than meclonazepam. These findings demonstrate the proof of concept that meclonazepam analogs can be designed with an improved therapeutic index, and point to the C3 position of the benzodiazepine ring system as a logical site for further structure-activity exploration to further optimize this chemical series.\n                <\/jats:p>","DOI":"10.1101\/2024.01.26.577323","type":"posted-content","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T13:45:39Z","timestamp":1706535939000},"source":"Crossref","is-referenced-by-count":1,"title":["Development of non-sedating antischistosomal benzodiazepines"],"prefix":"10.64898","author":[{"given":"Md Yeunus","family":"Mian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dishary","family":"Sharmin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Prithu","family":"Mondal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jawad Bin","family":"Belayet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M Mahmun","family":"Hossain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"McCusker","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaetlyn T.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander Y","family":"Fedorov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Heather A","family":"Green","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spencer S.","family":"Ericksen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9233-1760","authenticated-orcid":false,"given":"Mostafa","family":"Zamanian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"V. V. N. Phani Babu","family":"Tiruveedhula","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James M.","family":"Cook","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4986-972X","authenticated-orcid":false,"given":"John D.","family":"Chan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"54368","reference":[{"key":"2024013123401005000_2024.01.26.577323v1.1","doi-asserted-by":"crossref","first-page":"e327","DOI":"10.1016\/S1473-3099(22)00221-3","article-title":"Review of 2022 WHO guidelines on the control and elimination of schistosomiasis","volume":"22","year":"2022","journal-title":"Lancet Infect Dis"},{"key":"2024013123401005000_2024.01.26.577323v1.2","doi-asserted-by":"crossref","first-page":"e0009189","DOI":"10.1371\/journal.pntd.0009189","article-title":"Efficacy of praziquantel has been maintained over four decades (from 1977 to 2018): A systematic review and meta-analysis of factors influence its efficacy","volume":"15","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"2024013123401005000_2024.01.26.577323v1.3","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1038\/s41467-021-24958-0","article-title":"Whole-genome sequencing of Schistosoma mansoni reveals extensive diversity with limited selection despite mass drug administration","volume":"12","year":"2021","journal-title":"Nat Commun"},{"key":"2024013123401005000_2024.01.26.577323v1.4","first-page":"685\u2013695","article-title":"Laboratory induced resistance to praziquantel in experimental schistosomiasis","volume":"24","author":"Taha SA, Farghaly AM, el-Azony AS","year":"1994","journal-title":"J Egypt Soc Parasitol"},{"key":"2024013123401005000_2024.01.26.577323v1.5","first-page":"61","article-title":"Drug-resistant schistosomiasis: resistance to praziquantel and oxamniquine induced in Schistosoma mansoni in mice is drug specific","volume":"53","year":"1995","journal-title":"Am J Trop Med Hyg"},{"key":"2024013123401005000_2024.01.26.577323v1.6","doi-asserted-by":"crossref","first-page":"eabj9114","DOI":"10.1126\/scitranslmed.abj9114","article-title":"Genetic analysis of praziquantel response in schistosome parasites implicates a transient receptor potential channel","volume":"13","year":"2021","journal-title":"Sci Transl Med"},{"key":"2024013123401005000_2024.01.26.577323v1.7","doi-asserted-by":"publisher","DOI":"10.4269\/ajtmh.1999.60.932"},{"key":"2024013123401005000_2024.01.26.577323v1.8","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pntd.0000504"},{"key":"2024013123401005000_2024.01.26.577323v1.9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ijpddr.2020.04.001","article-title":"Why does oxamniquine kill Schistosoma mansoni and not S. haematobium and S. japonicum?","volume":"13","year":"2020","journal-title":"Int J Parasitol Drugs Drug Resist"},{"issue":"Suppl 5","key":"2024013123401005000_2024.01.26.577323v1.10","first-page":"123","article-title":"Metrifonate in schistosomiasis - therapy and prophylaxis","volume":"49","year":"1981","journal-title":"Acta Pharmacol Toxicol"},{"key":"2024013123401005000_2024.01.26.577323v1.11","first-page":"147\u2013148","article-title":"Ro 11-3128, a novel schistosomicidal compound","volume":"1","year":"1978","journal-title":"Proceedings of the 10th International Congress of Chemotherapy"},{"key":"2024013123401005000_2024.01.26.577323v1.12","first-page":"617\u2013618","volume":"55","year":"1979","journal-title":"Preliminary results in human schistosomiasis with Ro 11-3128. S Afr Med J"},{"key":"2024013123401005000_2024.01.26.577323v1.13","doi-asserted-by":"crossref","first-page":"742","DOI":"10.2307\/3280663","article-title":"Characteristics of antischistosomal benzodiazepine binding sites in Schistosoma mansoni","volume":"66","year":"1980","journal-title":"J Parasitol"},{"key":"2024013123401005000_2024.01.26.577323v1.14","first-page":"105528","article-title":"The anthelmintic meclonazepam activates a schistosome transient receptor potential channel","volume":"300","year":"2023","journal-title":"J Biol Chem"},{"key":"2024013123401005000_2024.01.26.577323v1.15","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/BF00389899","article-title":"Praziquantel, a new broad-spectrum antischistosomal agent","volume":"52","year":"1977","journal-title":"Zeitschrift f\u00fcr Parasitenkunde"},{"key":"2024013123401005000_2024.01.26.577323v1.16","doi-asserted-by":"publisher","DOI":"10.1038\/290514a0"},{"key":"2024013123401005000_2024.01.26.577323v1.17","doi-asserted-by":"crossref","unstructured":"Darragh A , Lambe R , Scully M , Brick I , O\u2019Boyle C , Downe WW . 1981. Investigation in man of the efficacy of a benzodiazepine antagonist, Ro 15\u20131788. Lancet 2:8\u201310.","DOI":"10.1016\/S0140-6736(81)90251-8"},{"key":"2024013123401005000_2024.01.26.577323v1.18","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2125.1986.tb02912.x"},{"key":"2024013123401005000_2024.01.26.577323v1.19","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/0378-4347(85)80105-5","article-title":"Plasma determination of 3-methylclonazepam by capillary gas chromatography","volume":"338","year":"1985","journal-title":"J Chromatogr"},{"key":"2024013123401005000_2024.01.26.577323v1.20","first-page":"163\u2013174","volume":"51","author":"International Helminth Genomes Consortium","year":"2019","journal-title":"Comparative genomics of the major parasitic worms. Nat Genet"},{"key":"2024013123401005000_2024.01.26.577323v1.21","first-page":"2019","article-title":"Non-sedating benzodiazepines cause paralysis and tissue damage in the parasitic blood fluke Schistosoma mansoni","volume":"15","author":"Phani Babu Tiruveedhula, Farjana Rashid, Lalit Kumar Golani, Ranjit S. Verma, Brian C. Smith, James","year":"2019","journal-title":"PLoS Negl Trop Dis Noember"},{"key":"2024013123401005000_2024.01.26.577323v1.22","unstructured":"Johnson H , VanHooreweghe M , Satori JA , Chan JD . 2023. Schistosomes contain divergent ligand-gated ion channels with an atypical Cys-loop motif. MicroPubl Biol 2023."},{"key":"2024013123401005000_2024.01.26.577323v1.23","doi-asserted-by":"publisher","DOI":"10.1038\/75761"},{"key":"2024013123401005000_2024.01.26.577323v1.24","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1007\/BF00507974","article-title":"A benzodiazepine derivative and praziquantel: effects on musculature of Schistosoma mansoni and Schistosoma japonicum","volume":"304","year":"1978","journal-title":"Archives Pharmacol"},{"key":"2024013123401005000_2024.01.26.577323v1.25","first-page":"e0010937","volume":"16","year":"2022","journal-title":"wrmXpress: A modular package for high-throughput image analysis of parasitic and free-living worms. PLoS Negl Trop Dis"},{"key":"2024013123401005000_2024.01.26.577323v1.26","doi-asserted-by":"crossref","unstructured":"Ryan KT , Wheeler NJ , Kamara IK , Johnson H , Humphries JE , Zamanian M , Chan JD . 2022. Phenotypic profiling of macrocyclic lactones on parasitic Schistosoma flatworms. bioRxiv.","DOI":"10.1101\/2022.09.12.507717"},{"key":"2024013123401005000_2024.01.26.577323v1.27","unstructured":"Szente A. 1977. Benzodiazepine derivatives. 4031078A. US Patent."},{"key":"2024013123401005000_2024.01.26.577323v1.28","doi-asserted-by":"crossref","unstructured":"Panic G , Ruf MT , Keiser J . 2017. Immunohistochemical Investigations of Treatment with Ro 13-3978, Praziquantel, Oxamniquine, and Mefloquine in Schistosoma mansoni-Infected Mice. Antimicrob Agents Chemother 61.","DOI":"10.1128\/AAC.01142-17"},{"key":"2024013123401005000_2024.01.26.577323v1.29","doi-asserted-by":"publisher","DOI":"10.1016\/0014-4894(86)90184-0"},{"key":"2024013123401005000_2024.01.26.577323v1.30","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0165-022X(02)00123-9","article-title":"Separation of oxazepam, lorazepam, and temazepam enantiomers by HPLC on a derivatized cyclodextrin-bonded phase: application to the determination of oxazepam in plasma","volume":"54","year":"2002","journal-title":"J Biochem Biophys Methods"},{"key":"2024013123401005000_2024.01.26.577323v1.31","doi-asserted-by":"publisher","DOI":"10.1038\/nature11691"},{"key":"2024013123401005000_2024.01.26.577323v1.32","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.bmcl.2008.02.077","article-title":"Meclonazepam analogues as potential new antihelmintic agents","volume":"18","year":"2008","journal-title":"Bioorg Med Chem Lett"},{"key":"2024013123401005000_2024.01.26.577323v1.33","first-page":"943\u2013949","article-title":"Alves MA, do Amaral DN, Thibaut JP, Noel F, Barreiro EJ, Lima LM","volume":"79","year":"2012","journal-title":"Synthesis, biological evaluation, and structure-activity relationship of clonazepam, meclonazepam, and 1,4-benzodiazepine compounds with schistosomicidal activity. Chem Biol Drug Des"},{"key":"2024013123401005000_2024.01.26.577323v1.34","first-page":"649","article-title":"The nature of 1,4-benzodiazepines\/receptor interactions","volume":"34","year":"1984","journal-title":"Arzneimittelforschung"},{"key":"2024013123401005000_2024.01.26.577323v1.35","doi-asserted-by":"publisher","DOI":"10.1016\/0014-2999(78)90085-7"},{"key":"2024013123401005000_2024.01.26.577323v1.36","first-page":"1086","volume":"33","year":"1983","journal-title":"De novo analysis of receptor binding affinity data of benzodiazepines. Arzneimittelforschung"},{"key":"2024013123401005000_2024.01.26.577323v1.37","first-page":"19","article-title":"Theoretical structure-activity studies of benzodiazepine analogues. Requirements for receptor affinity and activity","volume":"26","year":"1984","journal-title":"Mol Pharmacol"},{"key":"2024013123401005000_2024.01.26.577323v1.38","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1021\/acschembio.8b00144","article-title":"Different Benzodiazepines Bind with Distinct Binding Modes to GABAA Receptors","volume":"13","year":"2018","journal-title":"ACS Chem Biol"},{"key":"2024013123401005000_2024.01.26.577323v1.39","doi-asserted-by":"publisher","DOI":"10.1038\/s41586-018-0832-5"},{"key":"2024013123401005000_2024.01.26.577323v1.40","doi-asserted-by":"publisher","DOI":"10.1021\/jm00307a001"},{"key":"2024013123401005000_2024.01.26.577323v1.41","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1001\/jamapsychiatry.2014.1763","article-title":"Benzodiazepine use in the United States","volume":"72","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"2024013123401005000_2024.01.26.577323v1.42","doi-asserted-by":"crossref","first-page":"6412","DOI":"10.1021\/acs.orglett.1c02224","article-title":"Synthesis of \u03b1-Amino Acid N-Carboxyanhydrides","volume":"23","year":"2021","journal-title":"Org Lett"},{"key":"2024013123401005000_2024.01.26.577323v1.43","doi-asserted-by":"crossref","first-page":"e4792","DOI":"10.1002\/pro.4792","article-title":"UCSF ChimeraX: Tools for structure building and analysis","volume":"32","year":"2023","journal-title":"Protein Sci"},{"key":"2024013123401005000_2024.01.26.577323v1.44","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s13321-021-00522-2","article-title":"GNINA 1.0: molecular docking with deep learning","volume":"13","year":"2021","journal-title":"J Cheminform"},{"key":"2024013123401005000_2024.01.26.577323v1.45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13321-018-0285-8","article-title":"P2Rank: machine learning based tool for rapid and accurate prediction of ligand binding sites from protein structure","volume":"10","year":"2018","journal-title":"J Cheminform"}],"container-title":[],"original-title":[],"link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1101\/2024.01.26.577323","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T05:51:50Z","timestamp":1768456310000},"score":1,"resource":{"primary":{"URL":"http:\/\/biorxiv.org\/lookup\/doi\/10.1101\/2024.01.26.577323"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,29]]},"references-count":45,"URL":"https:\/\/doi.org\/10.1101\/2024.01.26.577323","relation":{},"subject":[],"published":{"date-parts":[[2024,1,29]]},"subtype":"preprint"}}